newsfilter
← Latest News
PR Newswire·

Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement

Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara"), a biopharmaceutical company investigating REM-001 in an NIH-sponsored and funded open label...